'We Should Follow That Signal': What We Heard This Week
(MedPage Today) -- "There is some signal there and we should follow that signal." -- John Carrino, MD, MPH, of Weill Cornell Medicine in New York City, in an FDA advisory committee meeting that supported RP1 (vusolimogene oderparepvec), a twice...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.